Quince Therapeutics, Inc.QNCXNASDAQ
LOADING
|||
Switch Symbol:
Net Income Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year net income growth rate
Latest
16.24%
↑ 201% above average
Average (30q)
-16.04%
Historical baseline
Range
High:80.19%
Low:-148.71%
Volatility
-1427.4%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | 16.24% |
| Q2 2025 | -6.78% |
| Q1 2025 | -20.65% |
| Q4 2024 | -126.84% |
| Q3 2024 | 80.19% |
| Q2 2024 | -148.71% |
| Q1 2024 | -25.35% |
| Q4 2023 | -66.21% |
| Q3 2023 | -9.52% |
| Q2 2023 | 60.13% |
| Q1 2023 | -121.43% |
| Q4 2022 | 30.14% |
| Q3 2022 | 52.18% |
| Q2 2022 | 23.46% |
| Q1 2022 | 7.51% |
| Q4 2021 | -7.80% |
| Q3 2021 | 0.22% |
| Q2 2021 | 5.77% |
| Q1 2021 | -12.31% |
| Q4 2020 | 4.42% |
| Q3 2020 | -22.11% |
| Q2 2020 | -2.54% |
| Q1 2020 | -38.75% |
| Q4 2019 | -25.57% |
| Q3 2019 | -8.78% |
| Q2 2019 | -59.51% |
| Q1 2019 | -63.72% |
| Q4 2018 | -37.64% |
| Q3 2018 | 18.89% |
| Q2 2018 | 7.97% |
| Q1 2018 | 0.00% |